Targeting PGE2 mediated senescent neuron improves tumor therapy
Neuro-Oncology · 2025
DOI: 10.1093/neuonc/noaf045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Jianyi Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Proton-Therapy, Shanghai, China. Hauptthemen laut MEDLINE: Dinoprostone, Cellular Senescence, Neurons, Glioblastoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Association for Science and Technology, Shanghai Science and Technology Innovation Action Plan.
Abstract (Originalsprache)
Background
Recent studies have highlighted bidirectional signaling between tumors and neurons; however, the interactions between tumors and neurons in response to radio-/chemotherapy remain obscure, which hampers the tumor treatment.
Methods
Glioblastoma organoids (GBOs) and primary neuron coculture, targeted metabonomics, RNA pulldown, mass spectrum, co-immunoprecipitation, RNA-sequencing, transcript/protein validations, and multi-electrode arrays were performed to analyze neuron-tumor interaction in response to therapy. In vivo validations were conducted in orthotopic mouse models. Diagnostic and prognostic values were evaluated in serum, tissue microarray as well as The Cancer Genome Atlas (TCGA).
Results
GBOs recruited and induced pro-tumor-survival senescent neurons upon radiation/chemotherapeutic treatment. Targeted metabonomics revealed that significantly increased tumor-derived prostaglandin E2 (PGE2) induced neuronal senescence phenotype. Screening of enzymes involved in PGE2 synthesis identified prostaglandin E synthase 3 (PTGES3) as the key enzyme responsible for PGE2 upregulation. Biochemical studies revealed that irradiation or chemotherapeutic drug-triggered asparagine endopeptidase (AEP) specifically cleaved eukaryotic translation initiation factor 4A1 (eIF4A1) to produce truncated C-terminal eIF4A1 (teIF4A1-C), which dissociated from DEAD-box helicase 6 (DDX6) and recruited eIF4A3 and polyadenylate-binding protein nuclear 1 (PABPN1) to promote the mRNA stability of PTGES3. Elevated PGE2 reciprocally enhanced AEP expression. Inhibiting PGE2 or AEP reduced neuronal senescence and delayed tumor progression. Strikingly, single-cell analysis further showed that expressions of AEP/PTGES3/EIF4A1 in tumor cells were consistent with senescent neuronal cyclin-dependent kinase inhibitor 1A (CDKN1A) in high-neuronal-connectivity glioblastoma. The serum PGE2 concentration was elevated after radiation and higher in resistant glioblastoma patients. High expression of PTGES3 was associated with a poor prognosis.
Conclusions
Our study revealed that the AEP/PGE2 feedback loop modulates tumor-induced neuronal senescence upon radio-/chemotherapy and highlights the therapeutic value to improve tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Proton-Therapy, Shanghai, China.
- Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Neurosurgery, Ren Ji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Neurosurgery, Sanya Central Hospital, The Third People's Hospital of Hainan Province, Hainan, China.
ORCID-Profile: Yingying Lin
Förderung
- National Natural Science Foundation of China
- Shanghai Association for Science and Technology
- Shanghai Science and Technology Innovation Action Plan
- National Key Research and Development Program of China
- Shanghai Hospital Development Center Foundation
- Scientific and Technological Innovation Action Plan of Shanghai Science and Technology Committee
- Beijing Science and Technology Innovation Medical Development Foundation
- Clinical Research of Shanghai Municipal Health Commission
Zitieren
APA
Zhao, J., Wu, L., Cai, G., Ou, D., Liao, K., Yang, J., Zhou, L., Huang, R., Lin, S., Huang, X., Lv, Q., Chen, J., Cao, L., Chen, J., & Lin, Y. (2025). Targeting PGE2 mediated senescent neuron improves tumor therapy. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf045
Vancouver
Zhao J, Wu L, Cai G, Ou D, Liao K, Yang J, et al. Targeting PGE2 mediated senescent neuron improves tumor therapy. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf045
BibTeX
@article{Zhao2025,
author = {Zhao, Jianyi and Wu, Linshi and Cai, Gang and Ou, Dan and Liao, Keman and Yang, Jian and Zhou, Li and Huang, Renhua and Lin, Shukai and Huang, Xi and Lv, Qi and Chen, Juxiang and Cao, Lu and Chen, Jiayi and Lin, Yingying},
title = {Targeting PGE2 mediated senescent neuron improves tumor therapy},
journal = {Neuro-Oncology},
year = {2025},
doi = {10.1093/neuonc/noaf045}
}
EUVIMED